Jennifer Rekemeyer

Senior Director, Learning And Development at Intellia Therapeutics

Jennifer Rekemeyer is a Senior Director of Learning and Development at Intellia Therapeutics, Inc., where responsibilities include building and executing long-term learning strategies, designing high-impact interventions, and establishing measurement criteria for development offerings. Previously, Jennifer served as Director of Leadership Development & Learning at bluebird bio, focusing on designing learning interventions and change management. Jennifer's extensive experience at Biogen includes various leadership roles that contributed to learning innovation, core employee programs, and change management strategies. Jennifer holds an MBA from Babson F.W. Olin Graduate School of Business, a BS in Leadership from Northeastern University, and an Associate's degree in Business from Marian Court Jr. College.

Location

Cambridge, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices


Intellia Therapeutics

9 followers

Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.


Industries

Employees

201-500

Links